BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24132298)

  • 1. The impact of pulmonary hypertension on morbidity and mortality following major lung resection.
    Wei B; D'Amico T; Samad Z; Hasan R; Berry MF
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1028-33. PubMed ID: 24132298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of perioperative Doppler echocardiography in patients undergoing major lung resection.
    Amar D; Burt ME; Roistacher N; Reinsel RA; Ginsberg RJ; Wilson RS
    Ann Thorac Surg; 1996 Feb; 61(2):516-20. PubMed ID: 8572758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.
    Burt BM; Kosinski AS; Shrager JB; Onaitis MW; Weigel T
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):19-28, dicussion 28-29.e1. PubMed ID: 24766848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung resection in patients with compromised pulmonary function.
    Cerfolio RJ; Allen MS; Trastek VF; Deschamps C; Scanlon PD; Pairolero PC
    Ann Thorac Surg; 1996 Aug; 62(2):348-51. PubMed ID: 8694589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing selection of patients for major lung resection.
    Ferguson MK; Reeder LB; Mick R
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):275-81; discussion 281-3. PubMed ID: 7853881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with preserved pulmonary function in non-small-cell lung cancer patients after video-assisted thoracic surgery.
    Kim SJ; Ahn S; Lee YJ; Park JS; Cho YJ; Cho S; Yoon HI; Kim K; Lee JH; Jheon S; Lee CT
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1084-90. PubMed ID: 26374869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%).
    Paul S; Andrews WG; Nasar A; Port JL; Lee PC; Stiles BM; Altorki NK
    Ann Am Thorac Soc; 2013 Dec; 10(6):616-21. PubMed ID: 24015712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    Zhang Z; Mostofian F; Ivanovic J; Gilbert S; Maziak DE; Shamji FM; Sundaresan S; Villeneuve PJ; Seely AJE
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):798-807. PubMed ID: 29103816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cardiopulmonary function on outcome of veterans undergoing resectional therapy for lung cancer.
    Canver CC; Cooler SD; Nichols RD
    J Cardiovasc Surg (Torino); 1998 Aug; 39(4):497-501. PubMed ID: 9788800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer.
    Pompili C; Velikova G; White J; Callister M; Robson J; Dixon S; Franks K; Brunelli A
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):526-531. PubMed ID: 28082473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
    Ferguson MK; Vigneswaran WT
    Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension after pneumonectomy for lung cancer.
    Potaris K; Athanasiou A; Konstantinou M; Zaglavira P; Theodoridis D; Syrigos KN
    Asian Cardiovasc Thorac Ann; 2014 Nov; 22(9):1072-9. PubMed ID: 24637028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.
    Corciova FC; Corciova C; Georgescu CA; Enache M; Anghel D; Bartos O; Tinica G
    Heart Surg Forum; 2012 Jun; 15(3):E127-32. PubMed ID: 22698598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of body mass index and outcomes after major lung resection.
    Ferguson MK; Im HK; Watson S; Johnson E; Wigfield CH; Vigneswaran WT
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):e94-9; discussion e99. PubMed ID: 24504655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise capacity assessment in patients undergoing lung resection.
    Bobbio A; Chetta A; Internullo E; Ampollini L; Carbognani P; Bettati S; Rusca M; Olivieri D
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):419-22. PubMed ID: 19138529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracoscopic lobectomy for non-small-cell lung cancer in patients with impaired pulmonary function: analysis from a national database.
    Bongiolatti S; Gonfiotti A; Vokrri E; Borgianni S; Crisci R; Curcio C; Voltolini L;
    Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):803-811. PubMed ID: 32249900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of wider parenchymal lung resection than preoperatively planned in patients with low preoperative lung function performance undergoing video-assisted thoracic surgery major lung resection.
    Kouritas VK; Kefaloyannis E; Milton R; Chaudhuri N; Papagiannopoulos K; Brunelli A
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):889-894. PubMed ID: 27516423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer.
    Villamizar NR; Darrabie M; Hanna J; Onaitis MW; Tong BC; D'Amico TA; Berry MF
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):514-20; discussion 520-1. PubMed ID: 23177123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.
    Eguchi T; Bains S; Lee MC; Tan KS; Hristov B; Buitrago DH; Bains MS; Downey RJ; Huang J; Isbell JM; Park BJ; Rusch VW; Jones DR; Adusumilli PS
    J Clin Oncol; 2017 Jan; 35(3):281-290. PubMed ID: 28095268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.